Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14778151 | 0.77 | ALDH1A1 (0.50) | ALDH1A1USP2TSHR | |
| SCHEMBL11094073 | 0.74 | TRPA1 (0.35) | ALDH1A1KDM4EUSP2LMNAMMP9 | |
| SCHEMBL3395529 | 0.73 | ALDH1A1 (0.38) | ALDH1A1KDM4EUSP2LMNAMMP9 | |
| SCHEMBL11155362 | 0.70 | ALDH1A1 (0.48) | ALDH1A1USP2TSHR | |
| SCHEMBL21404160 | 0.69 | KDM4E (0.32) | ALDH1A1KDM4EUSP2LMNAMMP9 | |
| SCHEMBL14779604 | 0.69 | ALDH1A1 (0.46) | ALDH1A1 | |
| SCHEMBL11150914 | 0.69 | ALDH1A1 (0.46) | ALDH1A1 | |
| SCHEMBL26137571 | 0.69 | ALDH1A1 (0.46) | ALDH1A1 | |
| SCHEMBL14780125 | 0.67 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL4812791 | 0.67 | KDM4E (0.33) | ALDH1A1KDM4EUSP2LMNAMMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130216723-A1 | SULFONATE ESTERS AS LATENT ACID CATALYSTS | KING INDUSTRIES (US) | 2013-08-22 | — | — | US | claimed |
| US-20090104363-A1 | Sulfonate esters as latent acid catalysts | KING INDUSTRIES | 2009-04-23 | — | — | US | claimed |
| US-4812215-A | SULFONIUM OR PHOSPHONIUM RESIN AMINOPLAST, LATENT ACID CATALYST | PPG INDUSTRIES, INC. (US) | 1989-03-14 | — | — | US | claimed |
| US-4477618-A | CROSSLINKING AN ACTIVE HYDROGEN-CONTAINING RESIN BLEND BY BAKING; STORAGE STABILITY | PPG INDUSTRIES, INC. (US) | 1984-10-16 | — | — | US | claimed |
| US-4812215-A | SULFONIUM OR PHOSPHONIUM RESIN AMINOPLAST, LATENT ACID CATALYST | PPG INDUSTRIES, INC. (US) | 1989-03-14 | — | — | US | disclosed |
| US-4477618-A | CROSSLINKING AN ACTIVE HYDROGEN-CONTAINING RESIN BLEND BY BAKING; STORAGE STABILITY | PPG INDUSTRIES, INC. (US) | 1984-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090104363-A1 | Sulfonate esters as latent acid catalysts | ORAI1, SARAF, NAPA | ALDH1A1 3647/4885KDM4E 506/4885USP2 4245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.